Audited Financial Results for the half Year and Year ended on 31st March, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.2 pts more than Nifty Microcap 250 and 5.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The source document for this BSE filing could not be retrieved — only a generic BSE 'Page Not Found' error message is available. As a result, no actual financial figures, auditor opinion, revenue numbers, profit/loss data, or balance sheet details can be analysed. The headline indicates the filing was meant to cover audited results for H2 FY26 and full year ended March 2026, but the underlying content is missing.
Investors cannot draw any conclusion about the company's performance or outlook from this filing as the actual results document was inaccessible. No price or sentiment impact can be assessed without the numbers.